198 related articles for article (PubMed ID: 23636606)
1. Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF.
Wu YY; Chen L; Wang GL; Zhang YX; Zhou JM; He S; Qin J; Zhu YY
J Mol Histol; 2013 Aug; 44(4):433-45. PubMed ID: 23636606
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous silencing of VEGF and KSP by siRNA cocktail inhibits proliferation and induces apoptosis of hepatocellular carcinoma Hep3B cells.
Doan CC; Le LT; Hoang SN; Do SM; Le DV
Biol Res; 2014 Dec; 47(1):70. PubMed ID: 25723613
[TBL] [Abstract][Full Text] [Related]
3. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.
Ye ZL; Huang Y; Li LF; Zhu HL; Gao HX; Liu H; Lv SQ; Xu ZH; Zheng LN; Liu T; Zhang JL; Jin HJ; Qian QJ
Acta Pharmacol Sin; 2015 Oct; 36(10):1237-45. PubMed ID: 25937637
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
5. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human hepatocellular carcinoma tumor angiogenesis by siRNA silencing of VEGF via hepatic artery perfusion.
Zou Y; Guo CG; Zhang MM
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4751-61. PubMed ID: 26744866
[TBL] [Abstract][Full Text] [Related]
7. Short interfering RNA targeting Net1 reduces the angiogenesis and tumor growth of in vivo cervical squamous cell carcinoma through VEGF down-regulation.
Zhang Y; Xia P; Zhang W; Yan M; Xiong X; Yu W; Song E
Hum Pathol; 2017 Jul; 65():113-122. PubMed ID: 28511963
[TBL] [Abstract][Full Text] [Related]
8. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
9. Proliferation inhibition and apoptosis promotion by dual silencing of VEGF and Survivin in human osteosarcoma.
Gu J; Ji Z; Li D; Dong Q
Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):59-67. PubMed ID: 30566604
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
[TBL] [Abstract][Full Text] [Related]
11. Promotive effects of bone morphogenetic protein 2 on angiogenesis in hepatocarcinoma via multiple signal pathways.
Zuo WH; Zeng P; Chen X; Lu YJ; Li A; Wu JB
Sci Rep; 2016 Nov; 6():37499. PubMed ID: 27886213
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 Knockdown Decreases SMMC7721 Human Hepatocellular Carcinoma Cell Invasiveness by Inhibiting Vascular Endothelial Growth Factor-Induced Angiogenesis.
Zhang ZB; Shi Z; Yang LF; Gao HB
Can J Gastroenterol Hepatol; 2020; 2020():8880888. PubMed ID: 32676485
[TBL] [Abstract][Full Text] [Related]
14. Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication.
Kunanopparat A; Issara-Amphorn J; Leelahavanichkul A; Sanpavat A; Patumraj S; Tangkijvanich P; Palaga T; Hirankarn N
World J Gastroenterol; 2018 Sep; 24(34):3861-3870. PubMed ID: 30228780
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17F suppresses hepatocarcinoma cell growth via inhibition of tumor angiogenesis.
Xie Y; Sheng W; Xiang J; Ye Z; Yang J
Cancer Invest; 2010 Jul; 28(6):598-607. PubMed ID: 20210523
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
[TBL] [Abstract][Full Text] [Related]
17. The effects of RNA interference mediated VEGF gene silencing on biological behavior of renal cell carcinoma and transplanted renal tumor in nude mice.
Wang Q; Wang S; Sun SQ; Cheng ZH; Zhang Y; Chen G; Gu M; Yao HJ; Wang Z; Zhou J; Peng YB; Xu MX; Zhang K; Sun XW
Cancer Biomark; 2016; 16(1):1-9. PubMed ID: 26484606
[TBL] [Abstract][Full Text] [Related]
18. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
19. Dual gene targeted multimeric siRNA for combinatorial gene silencing.
Lee SH; Mok H; Jo S; Hong CA; Park TG
Biomaterials; 2011 Mar; 32(9):2359-68. PubMed ID: 21183215
[TBL] [Abstract][Full Text] [Related]
20. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]